Main > A1. CORP. INDEX. A-Am No. 1 > Alexion Pharmaceuticals/P C2

This data is not available for free

Alexion Pharmaceuticals/P C2's subsections
2002. 09.23.2002. (Arthritis)
2003. 01.13.2003. (Arthritis)
2003. 01.13.2003. (Focus)
2003. 02.03.2003. (Arthritis)
2004. 11.10.2004. Cardio
2004. 11.10.2004. Executive
2010. 04.16. Hemato>PNH E
2010. 06.15. Blood Coag>TMA
2010. 12.05. Onco>MAb
2011. 01.31. Corp. & IP Acq.
2011. 02.10. Patent Acq.
2011. 06.20. STEC-HUS
2011. 09.15. Neuro.>gMG
2013. 06.17. Global HQ.
2013. 09.10. Nephro>Kidney AMR
2013. 10.24. MoCD Type A
2014. 01.13. Moderna Therapeutics
2014. 05.05. Blood Coag>AHUS
2014. 06.23. Cincinnati Children
2015. 05.06. Acq. Synageva Bio
2015. 10.23. HPP
2016. 03.28. LAL-D
2018. 04.11. Acq Wilson Therapeutic
2018. 06.11. Complement Pharma
2018. 09.26. Acq. Syntimmune
2018. 12.21. Hemato>PNH R USA>OK
2019. 03.20. Affibody AB.
2019. 03.20. Zealand Pharma
2019. 06.18. Hemato>PNH R JP>OK
2019. 06.27. Neuro.>NMOSD>USA>OK
2019. 07.03. Hemato>PNH R EU>OK
2019. 08.27. Neuro.>NMOSD>EU>OK
2019. 10.16. Acq. Achillion Pharma.
2019. 10.18. AHUS
2019. 11.22. Neuro.>NMOSD>JP>OK
2020. 05.05. Acq. Portola Pharma.
2020. 06.29. Hemato.>aHUS>EU>OK
2020. 09.25. Hemato.>aHUS>JP>OK
2020. 12.12. Acq. By AstraZeneca
2022. 04.28. Neuro.>gMG>AChR+>
2024. 03.25. Neuro.>NMOSD>USA>OK
Patents
Technology Platforms C2
Web-Site
Z - OK

Alexion Pharmaceuticals/P C2's products
This section has no products